Berkeley, CA, United States of America

Marlon Thompson

This inventor holds 2 USPTO granted patents. Top assignee: University of California. Active years: 2005-2010.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2005-2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Marlon Thompson: Innovator in Chelating Agents

Introduction

Marlon Thompson is a notable inventor based in Berkeley, CA. He has made significant contributions to the field of chelating agents, particularly in applications related to magnetic resonance imaging. With a total of 2 patents, Thompson's work has garnered attention in both academic and medical circles.

Latest Patents

Thompson's latest patents focus on hydroxypyridonate and hydroxypyrimidinone chelating agents. These inventions provide innovative solutions by offering Gd(III) complexes of these agents, which serve as effective contrast-enhancing agents for magnetic resonance imaging. The patents also detail methods for preparing these compounds and their applications in MRI, showcasing Thompson's commitment to advancing medical imaging technology.

Career Highlights

Thompson is affiliated with the University of California, where he continues to engage in research and development. His work has not only contributed to the scientific community but has also paved the way for improved diagnostic techniques in medicine.

Collaborations

Some of Thompson's notable coworkers include Kenneth N Raymond and Daniel M J Doble. Their collaborative efforts have further enriched the research environment and fostered innovation in their respective fields.

Conclusion

Marlon Thompson's contributions to the development of chelating agents highlight his role as an influential inventor in the medical imaging sector. His patents reflect a dedication to enhancing diagnostic capabilities, ultimately benefiting healthcare professionals and patients alike.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…